CompaniesHarrison Clinical Research

Harrison Clinical Research

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (15)
View all

Total Trials

15

As Lead Sponsor

1

As Collaborator

14

Total Enrollment

2,033

By Phase

PHASE2: 4PHASE1: 6NA: 2PHASE1/PHASE2: 1PHASE3: 1

By Status

COMPLETED: 12WITHDRAWN: 1TERMINATED: 1UNKNOWN: 1
Clinical Trials Pipeline15 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00820417
Hover over trial bars to see details

Recent Trials

NCT06779981Collaborator
A Prospective Epidemiological Study Evaluating Occurrences of Influenza-like Illness
N/ACompleted
119 participants
Started: Dec 13, 2024 · Completed: Jun 19, 2025
NCT06582277Collaborator
Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836
PHASE2Completed
117 participants
Started: Oct 22, 2024 · Completed: Jun 2, 2025
NCT05684718Collaborator
To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100
PHASE1Completed
16 participants
Started: Feb 1, 2023 · Completed: Oct 31, 2023
NCT05537142Collaborator
A Study to Assess the Phamacokinetics of BV100 in Participants with Varying Degrees of Hepatic Impairment
PHASE1Completed
33 participants
Started: Sep 2, 2022 · Completed: Oct 30, 2024
NCT05537090Collaborator
A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants
PHASE1Completed
16 participants
Started: Sep 1, 2022 · Completed: Sep 30, 2023
View all 15 trials →
Related Companies
Synteract
merged